Definium Therapeutics, Inc. is receiving analyst coverage from Royal Bank of Canada and Needham & Company.
5 reports, 1 independent
Updated Sep 15
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 5
- Developments
- 1
- Repetition
- 80%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Definium Therapeutics, Inc. is receiving analyst coverage from Royal Bank of Canada and Needham & Company.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Royal Bank of Canada
financial institution in Canada
-
Needham & Company
American independent investment bank and asset management firm
Related events
- Royal Bank of Canada increased its stock holdings in Option Care Health, Inc., which trades on the Nasdaq exchange, and the company filed disclosures with the SEC.
- Royal Bank of Canada increased its stock position in Real Brokerage Inc., which is listed on Nasdaq, while Edward Jones issued a rating update.
- EverCommerce Inc. is trading on the Nasdaq stock exchange, and MarketBeat is providing consensus ratings while Royal Bank of Canada reduced its price target.
- William P. Blair, Bank of America, and Royal Bank of Canada issued rating updates and price targets for Standard Nuclear, Inc.
- Pensionbee Group PLC received an outperform rating restatement and a buy rating reiteration from financial institutions.